These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy. Cohn PF Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587 [TBL] [Abstract][Full Text] [Related]
3. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy. Belardinelli R Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102 [TBL] [Abstract][Full Text] [Related]
5. [Combination of anti-angina drugs]. Silber S Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981 [TBL] [Abstract][Full Text] [Related]
6. Beneficial actions of nitrates in cardiovascular disease. Abrams J Am J Cardiol; 1996 May; 77(13):31C-7C. PubMed ID: 8638524 [TBL] [Abstract][Full Text] [Related]
7. Calcium antagonists or beta-blockers in chronic ischaemic left ventricular dysfunction? Pouleur H Eur Heart J; 1993 Oct; 14 Suppl F():26-8. PubMed ID: 7903245 [TBL] [Abstract][Full Text] [Related]
8. API expert consensus document on management of ischemic heart disease. Association of Physicians of India J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Abrams J Am J Cardiol; 1992 Sep; 70(8):30B-42B. PubMed ID: 1529924 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic profiles of antianginal agents. Tonkon M Pharmacotherapy; 1987; 7(5 Pt 2):72S-75S. PubMed ID: 3324061 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs]. Noll G; Kaufmann U; Wenzel RR; Lüscher TF Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687 [TBL] [Abstract][Full Text] [Related]
14. The reduction of infarct size--forty years of research. Ferreira R Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. Ruffolo RR; Feuerstein GZ Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017 [TBL] [Abstract][Full Text] [Related]
16. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry. Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L; Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928 [TBL] [Abstract][Full Text] [Related]
17. Unstable angina. Rational approach to management. Flaherty JT Am J Med; 1984 Jun; 76(6A):52-7. PubMed ID: 6146257 [TBL] [Abstract][Full Text] [Related]